Go Pro
→ Rickards Predicts: Trump to buy tiny $2 stock? (From Paradigm Press) (Ad)tc pixel Free GANX Stock Alerts

Gain Therapeutics (GANX) Stock Chart & Stock Price History

Gain Therapeutics logo
$2.12 +0.15 (+7.32%)
As of 12:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Gain Therapeutics Stock Price Performance

The Gain Therapeutics (GANX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 21.17%, with a year-to-date return of -32.27%. In the past month, the stock has increased 11.85%, reflecting recent market activity.

As of the latest close, Gain Therapeutics traded at $1.98 with a market cap of $84.45 million and volume of 11.51 million shares. Five years ago, the stock traded at $10.00, representing a 78.19% decrease over that period. At the time, it had a market cap of $123.28 million and a volume of 10,464 shares.

Receive GANX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gain Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+26.80%
1 Month
Performance
+11.85%
3 Month
Performance
+21.17%
Year-To-Date
Performance
-32.27%
1 Year
Performance
+21.17%
5 Year
Performance
-78.19%

GANX Stock Chart for Tuesday, June, 30, 2026

GANX Chart by TradingView

Gain Therapeutics Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
06/29/2026$1.75$1.98
+13.14%		$1.99$1.7511.51 million shs$84.45 million
06/26/2026$1.72$1.75
+1.74%		$1.77$1.68522,387 shs$74.64 million
06/25/2026$1.74$1.72
-1.15%		$1.75$1.71283,869 shs$73.36 million
06/24/2026$1.77$1.74
-1.69%		$1.87$1.74272,156 shs$74.22 million
06/23/2026$1.85$1.77
-4.32%		$1.90$1.77378,818 shs$75.49 million
06/22/2026$1.88$1.85
-1.60%		$1.95$1.84790,948 shs$78.90 million
06/19/2026$1.88$1.88$1.90$1.80499,893 shs$80.18 million
06/18/2026$1.78$1.88
+5.62%		$1.90$1.80499,893 shs$80.18 million
06/17/2026$1.79$1.78
-0.56%		$1.88$1.77381,716 shs$75.92 million
06/16/2026$1.75$1.79
+2.29%		$1.86$1.77599,969 shs$76.34 million
06/15/2026$1.68$1.75
+4.17%		$1.79$1.70447,086 shs$74.64 million
06/12/2026$1.69$1.68
-0.59%		$1.71$1.64482,863 shs$71.65 million
06/11/2026$1.64$1.69
+3.05%		$1.70$1.60530,955 shs$72.09 million
06/10/2026$1.65$1.64
-0.61%		$1.75$1.62362,281 shs$69.95 million
06/09/2026$1.69$1.65
-2.37%		$1.70$1.561.30 million shs$70.37 million
06/08/2026$1.70$1.69
-0.59%		$1.76$1.66544,630 shs$72.09 million
06/05/2026$1.86$1.70
-8.60%		$1.84$1.68615,211 shs$72.51 million
06/04/2026$1.79$1.86
+4.20%		$1.90$1.79369,388 shs$79.33 million
06/03/2026$1.83$1.79
-2.46%		$1.85$1.76374,799 shs$76.13 million
06/02/2026$1.96$1.83
-6.63%		$1.92$1.82887,644 shs$83.60 million
06/01/2026$1.95$1.96
+0.51%		$2.03$1.901.15 million shs$83.59 million
05/29/2026$2.02$1.95
-3.47%		$2.04$1.88868,684 shs$83.17 million
Related Companies

This page (NASDAQ:GANX) was last updated on 6/30/2026 by MarketBeat.com Staff.
From Our Partners
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Solar is dead. Here’s what replaces it.
Starting July 4th, every new solar and wind project in America loses its federal tax credits. But one zero-car...
Behind the Markets | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
The rulebook on retirement didn't just get rewritten... It got shredded. Inflation quietly eroded purchasin...
Money Pickle | Sponsoredtc pixel
QNC: Protecting the AI Revolution Against Tomorrow’s Threats!
As AI infrastructure expands, so does its vulnerability to quantum-era threats. Quantum eMotion (QNC) is addre...
Huge Alerts | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel